Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children
Pg. Holt et al., Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children, J ALLERG CL, 105(6), 2000, pp. 1117-1122
Background: Recent findings suggest that a hallmark of the atopic phenotype
is reduced capacity to respond to vaccine antigens, as well as to environm
ental allergens, during infancy. This deficiency, which is most marked for
the cytokine IFN-gamma, appears transient but can result in a long-lasting
imbalance within T helper cell (T-H) memory responses to allergens. Indirec
t evidence suggests that parallel effects may occur within immunologic memo
ry responses against vaccine antigens in atopic children.
Objective: Our purpose was to compare vaccine antigen-specific T-H memory r
esponses in atopic and nonatopic children.
Methods: We analyzed specific serum IgG and cytokine responses to pertactin
and tetanus antigens as well as to mitogen (PHA) and house dust mite (HDM)
allergen in 25 HDM-sensitized atopic and 25 nonatopic 6-year-old children
who were vaccinated and boosted with diphtheria-tetanus-pertussis (DTP) vac
cine.
Results: PBMCs from the atopic subjects produced higher levels of T(H)1 and
T(H)2 cytokines to HDM allergen and PHA. Vaccine antibody titers were norm
al in the atopic subjects; vaccine-specific T(H)2 responses were rarely det
ectable, yet T(H)1 (IFN-gamma) responses, in particular against tetanus, we
re frequent and higher in the atopic subjects (121.5 [SE 64.3] vs 8.0 [3.5]
pg/mL culture fluid, P = .04). Corresponding pertactin responses were comp
arable in both groups.
Conclusions: At the completion of the full primer-booster DTP vaccination r
egimen, levels of vaccine-specific immunity in atopic 6-year-old children a
re at least equivalent to their nonatopic counterparts, indicating that the
transient atopy-associated deficiency in T(H)1 function in childhood can b
e successfully overcome by appropriate vaccination and boosting regimens.